The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1705
ISSUE1705
Med Lett Drugs Ther. 2024 Jun 24;66(1705):104 doi:10.58347/tml.2024.1705h
Disclosures
Objective(s)
Our recent article on Drugs for Hypertension (Med Lett Drugs Ther 2024; 66:81) described both the Paradise and Symplicity Spyral renal denervation devices as ultrasound devices. That is true for the Paradise device, but Symplicity Spyral uses radiofrequency ablation.
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article